Inspired by recent breakthrough discoveries, we are dedicated to eradicating cancer and are excited about our progress—to date, we have advanced three molecularly targeted therapies and an immuno-oncology treatment into clinical trials. We think our product candidates have the potential to be life-saving, bringing much needed therapies to patients with few treatment options. We are dedicated to changing the course of cancer therapy to better the lives of millions of patients and their families around the world.